1Brunner, EJ, Rees, K, Ward, K, et al. (2007) Dietary advice for reducing cardiovascular risk. The Cochrane Database of Systematic Reviews, .
2Van Horn, L, McCoin, M, Kris-Etherton, PM, et al. (2008) The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 108, 287–331.
4Asp, N-G, Cummings, JH, Mensink, RP, et al. (2003) PASSCLAIM Phase one: preparing the way. Eur J Nutr 42, Suppl. 1, 1–119.
5Asp, N-G, Cummings, JH, Howlett, J, et al. (2004) PASSCLAIM Phase two: moving forward. Eur J Nutr 43, Suppl. 2, 1–183.
7Moher, D, Hopewell, S, Schulz, KF, et al. (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340, c869.
8Sandstrom, B (1995) Quality criteria in human experimental nutrition research. Eur J Clin Nutr 49, 315–322.
10AbuMweis, SS, Jew, S & Jones, PJ (2010) Optimizing clinical trial design for assessing the efficacy of functional foods. Nutr Rev 68, 485–499.
11Klein, MA, Nahin, RL, Messina, MJ, et al. (2010) Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr 140, 1192S–1204S.
12Shane, AL, Cabana, MD & Vidry, S (2010) Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 1, 243–253.
13Aggett, PJ, Antoine, J-M, Asp, N-G, et al. (2005) PASSCLAIM process for the assessment of scientific support for claims on foods: consensus on criteria. Eur J Nutr 44, Suppl. 1, 1–30.
14EFSA (2007) Scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim. EFSA J 530, 1–44.
19Jones, PJH, Asp, N-G & Silva, P (2008) Evidence for health claims on foods: how much is enough? Introduction and general remarks. J Nutr 138, S1192–S1227.
22Moher, D & Tricco, AC (2008) Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr 88, 1191–1199.
23Pocock, SJ (1983) Clinical Trials: A Practical Approach. Chichester: John Wiley & Sons.
24Piantadosi, S (2005) Clinical Trials: A Methodological Perspective, 2nd ed.Hoboken, NJ: John Wiley & Sons.
25Machin, D & Fayers, P (2010) Randomized Clinical Trials: Design, Practice and Reporting. Chichester: Wiley-Blackwell.
26Friedman, LM, Furberg, CD & DeMets, DL (2010) Fundamentals of Clinical Trials, 4th ed.New York: Springer.
27Peace, KE & Chen, D (2011) Clinical Trial Methodology. Boca Raton, FL: Chapman & Hall/CRC.
28UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853.
29Mensink, RP, Aro, A, Den Hond, E, et al. (2003) PASSCLAIM – diet-related cardiovascular disease. Eur J Nutr 42, Suppl. 1, 6–27.
30Prentice, A, Bonjour, JP, Branca, F, et al. (2003) PASSCLAIM – bone health and osteoporosis. Eur J Nutr 42, Suppl. 1, 28–49.
31Zhang, X, Yap, Y, Wei, D, et al. (2008) Novel omics technologies in nutrition research. Biotechnol Adv 26, 169–176.
32Winawer, SJ, Zauber, A, Ho, MN, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Eng J Med 329, 1977–1981.
33Perez-Martinez, P, Yiannakouris, N, Lopez-Miranda, J, et al. (2008) Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in white populations. Am J Clin Nutr 87, 744–752.
34Lee, Y-M, Skurk, T, Hennig, M, et al. (2007) Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 46, 21–27.
35Brink, E, Coxam, V, Robins, S, et al. (2008) Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 87, 761–770.
39Krleza-Jeric, K (2005) Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med 2, e378.
40Bingham, SA (1991) Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab 35, 17–27.
44Hills, M & Armitage, P (2004) The two-period cross-over clinical trial. Br J Clin Pharmacol 58, S703–S716.
45Matthews, JN, Altman, DG, Campbell, MJ, et al. (1990) Analysis of serial measurements in medical research. BMJ 300, 230–235.
46Rowe, SR, Alexander, N, Clydesdale, F, et al. (2009) Funding food science and nutrition research: financial conflicts and scientific integrity. Nutr Rev 67, 264–272.